Logo

EMPG

Empro Group Inc. Ordinary shares

EMPG

Empro Group Inc. Ordinary shares • NASDAQ
$17.36 ▲ 0.00% (+0.00)
Market Cap $143.05 M
52w High $18.14
52w Low $2.55
Dividend Yield 0%
P/E 192.89
Volume 386.37K
Outstanding Shares 8.24M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2024 $108.657K ▲ $4.589M ▲ $3.062M ▲ $1.527M ▲
Q2-2024 $38.219K ▼ $2.861M ▼ $2.431M ▼ $430.826K ▼
Q4-2023 $283.158K $3.783M $3.042M $741.214K

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow

Five-Year Company Overview

Income Statement

Income Statement The reported income statement gives almost no meaningful detail: revenue appears extremely small and all the usual profit measures are shown as flat, which suggests either very limited operations in the reported period or incomplete disclosure. The earnings-per-share figures move around over time, but without any underlying sales, margin, or cost detail, it is hard to tell whether the business is truly profitable or if these movements are driven by accounting and capital structure changes tied to the SPAC listing. Overall, the financial picture from the income statement is opaque and does not yet tell a clear story of scale or earnings quality.

Balance Sheet

Balance Sheet The balance sheet data provided are essentially blank, with no visible assets, cash, debt, or equity over several years. This likely reflects either missing data or a structure where historical figures tied to the SPAC shell do not line up with the current operating company. Because of this, it is not possible to gauge how strong Empro’s financial foundation is, how much cushion it has to absorb shocks, or how reliant it might be on outside financing.

Cash Flow

Cash Flow The cash flow information is also empty, with no reported operating, investing, or free cash flow. That means there is no visibility into whether the core business is generating cash, consuming it, or how capital spending is being funded. For a young, expanding brand, this lack of cash-flow detail makes it difficult to judge the sustainability of growth plans or the company’s ability to weather weaker periods.

Competitive Edge

Competitive Edge Commercially, Empro operates as a niche beauty and personal care player with roots in Malaysia, built around eyebrow products, skincare, and some healthcare and protective items like masks and gloves. Its strengths lie in brand recognition in its home market, distinctive product designs such as its eyebrow pencil, and a multi-brand strategy targeted at different consumer segments and sales channels, including live shopping. At the same time, it competes against very large global beauty groups and many agile local brands, which makes sustained differentiation and marketing execution critical. The recent trading halt on its shares also introduces reputational and financing uncertainty that could weigh on its competitive standing if it lingers.

Innovation and R&D

Innovation and R&D Empro’s innovation seems focused on practical product design, proprietary shapes and formats, and branded formulations rather than heavy laboratory research. Examples include the patented fit technology in its masks, a distinctive eyebrow pencil design, and a skincare line marketed around specific botanical ingredients and visible effects. The company is also experimenting with new commercial formats, such as brands tailored to live shopping and younger digital audiences, which is a form of business-model innovation. However, there is limited public detail on how much it spends on research and development or how robust its pipeline of genuinely new products is beyond these highlighted items.

Summary

Overall, Empro today looks more like an emerging brand story than a proven financial story: the narrative around niche positioning, product design, and digital-savvy marketing is far clearer than the hard financial evidence of scale and profitability. The SPAC route to a U.S. listing and the subsequent trading halt add layers of regulatory and disclosure uncertainty that overshadow the limited financial data available. Key unknowns include the true size and growth of its revenue base, the health of its balance sheet, and its cash generation or burn rate. Going forward, the most important signals will likely be clearer audited financials, resolution of the trading halt, and evidence that its product and channel innovations translate into durable brand strength and consistent operating performance.

NEWS

October 23, 2025 · 6:00 AM UTC

Nasdaq Halts Empro Group Inc.

Read more